Need professional-grade analysis? Visit stockanalysis.com
$7.67B
26.92
925
0.96%
Zylox-Tonbridge Med Tech Co (2190) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD23.38, down 2.50% from the previous close.
Over the past year, 2190 has traded between a low of HKD18.04 and a high of HKD27.50. The stock has gained 20.6% over this period. It is currently 15.0% below its 52-week high.
Zylox-Tonbridge Med Tech Co has a market capitalization of $7.67B, with a price-to-earnings ratio of 26.92 and a dividend yield of 0.96%.
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.